Use of low-dose OKT3 as induction therapy in liver transplantation

Transplantation

Volumn 65, Issue 4, 1998, Pages 577-580

  Whiting, James F ^a,b   Fecteau, Annie ^a   Martin, Jill ^a   Bejarano, Pablo A ^a   Hanto, Douglas W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; OKT 3; PREDNISOLONE;

ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEVER; HUMAN; HYPOTENSION; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; AZATHIOPRINE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MUROMONAB-CD3; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; SURVIVAL RATE;

EID: 0032570753     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00022     Document Type: Article

References (10)

1. The U.S. Multicenter FK506 Liver Study Group. A comparision of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
2. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
3. McDiarmid SV, Millis MJ, Terasaki PI, Ament ME, Busuttil RW. OKT3 prophylaxis in liver transplantation. Dig Dis Sci 1991; 36: 1418.
4. Wall WJ, Ghent CN, Roy A, McAlister VC, Grant DR, Adams PC. Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation. Dig Dis Sci 1995; 40: 52.
5. Fung J, Starzl T. Prophylactic use of OKT3 in liver transplantation: a review. Dig Dis Sci 1991; 36: 1427.
6. Anonymous. Orthoclone OKT3 (muromonab-CD3) package insert. Raritan, NJ: Ortho Biotech Inc., 1995
7. Norman DJ, Kimball JA, Bennett WM, Et al. A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation. Transpl Int 1994; 7: 356.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128.
9. Covelli HD, Nessan VJ, Tuttle WKI. Oxygen derived variables in acute respiratory failure. Crit Care Med 1983; 11: 646.
10. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987; 11: 1.